Comparison of Efficacy of Bupivacaine in Supraclavicular Block With or Without Dexmedetomidine

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Pain
Interventions
DRUG

DEXmedetomidine

28 mL of Bupivacain 0.25% was mixed with Dexmedetomidine 1 microgram/kg body weight mixed in 2 mL = total volume 30 mL

OTHER

saline

28 mL of Bupivacain 0.25% was mixed with 2 mL of Normal saline = total volume 30 mL

Trial Locations (1)

74200

Syed Muhammad Abbas, Karachi

All Listed Sponsors
lead

Sindh Institute of Urology and Transplantation

OTHER

NCT05991375 - Comparison of Efficacy of Bupivacaine in Supraclavicular Block With or Without Dexmedetomidine | Biotech Hunter | Biotech Hunter